NCT07746596Completed
Su Jok for Dyspnea and Fatigue
Effects of Su Jok Therapy on Dyspnea and Fatigue in Patients With Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 10 Aug 2026
Brief summary (registry, in English)
As the disease progresses, dyspnea and fatigue may increasingly interfere with daily activities, reduce patients' independence, and negatively affect their quality of life. Therefore, in addition to pharmacological treatment, there is a need for safe and supportive interventions to help alleviate these symptoms. This study aims to evaluate the effects of Su Jok therapy on dyspnea and fatigue in patients with chronic obstructive pulmonary disease (COPD). The findings are expected to provide evidence regarding the potential role of Su Jok therapy as a complementary intervention for symptom management. The results may contribute to improving patients' symptom control and quality of life while providing healthcare professionals with evidence to support clinical decision-making and nursing care.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 31 Jul 2026
- Start date
- 2 Jan 2026
- Primary completion date
- 31 Jul 2026
- Lead sponsor
- Erzincan Binali Yildirim Universitesi
- Diseases
- COPD
- NCT number
- NCT07746596
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 2 Jan 2026 to the primary completion date, 31 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Conditions preventing the application of Su Jok therapy to the hands, including neuropathy, amputation, open wounds, or other hand disorders.
Other
- Declined or were unable to provide written informed consent.
- Unable to communicate verbally.
Who the study is looking for
- Adults aged 18 years or older.
- Diagnosed with chronic obstructive pulmonary disease (COPD).
- Able to communicate verbally.
- Expected to remain hospitalized for at least 5 days to ensure completion of the intervention.
- No major health condition other than COPD that could adversely affect activities of daily living (e.g., open wounds, cancer, or gastrointestinal disorders).
- Provided written informed consent to participate in the study.
- A Visual Analog Scale (VAS) score of 3 or higher for dyspnea and fatigue.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Erzincan Binali Yıldırım University Coordinator of this site? Confirm its status | Erzincan | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.